Provided by Tiger Trade Technology Pte. Ltd.

Profound Medical Corp.

5.61
+0.20003.70%
Post-market: 5.45-0.1600-2.85%16:41 EDT
Volume:237.85K
Turnover:1.29M
Market Cap:203.60M
PE:-3.98
High:5.62
Open:5.41
Low:5.24
Close:5.41
52wk High:8.95
52wk Low:3.76
Shares:36.29M
Float Shares:33.94M
Volume Ratio:0.35
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4081
EPS(LYR):-1.4081
ROE:-67.12%
ROA:-34.91%
PB:3.06
PE(LYR):-3.98

Loading ...

Company Profile

Company Name:
Profound Medical Corp.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
162
Office Location:
2400 Skymark Avenue,Unit 6,Mississauga,Ontario,Canada
Zip Code:
L4W 5K5
Fax:
647 847 3739
Introduction:
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, palliative pain treatment of bone metastases, and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga, Canada.

Directors

Name
Position
Arun Menawat
Chair of the Board and Chief Executive Officer and Director
Brian Ellacott
Lead Independent Director
Arthur Rosenthal
Director
Cynthia Lavoie
Director
Kris Shah
Director
Murielle Lortie
Director

Shareholders

Name
Position
Arun Menawat
Chair of the Board and Chief Executive Officer and Director
Rashed Dewan
Chief Financial Officer
Mathieu Burtnyk
President
Tom Tamberrino
Chief Commercial Officer